Gene: LRP2BP
Official Full Name: LRP2 binding proteinprovided by HGNC
Gene Summary: Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02572 | LRP2BP Knockout cell line (HeLa) | Human | LRP2BP | 1:3~1:6 | Negative | Online Inquiry |
KO02573 | LRP2BP Knockout cell line (HCT 116) | Human | LRP2BP | 1:2~1:4 | Negative | Online Inquiry |
KO02574 | LRP2BP Knockout cell line (HEK293) | Human | LRP2BP | 1:3~1:6 | Negative | Online Inquiry |
LRP2BP Gene Knockout Cell Lines are specialized cellular models engineered to specifically disrupt the LRP2BP (Low-Density Lipoprotein Receptor-Related Protein 2 Binding Protein) gene. This sophisticated tool is designed to facilitate the study of gene function, protein interactions, and molecular pathways influenced by LRP2BP in various biological contexts. By employing advanced CRISPR-Cas9 technology, these cell lines provide a precise means to investigate the effects of LRP2BP deficiency on cellular mechanisms and disease states.
The primary function of LRP2BP is to mediate intracellular signaling pathways, particularly those involved in lipid metabolism and receptor trafficking. The knockout of this gene enables researchers to elucidate its role in cellular homeostasis, particularly in the context of neurodegenerative diseases and metabolic disorders where lipid transport is critically involved. In preclinical studies, these cell lines can serve as valuable models to assess the impact of therapeutic interventions that target signaling pathways modulated by LRP2BP.
The scientific importance of LRP2BP Gene Knockout Cell Lines is underscored by their applications across various research and clinical settings. Researchers can utilize these models to validate hypotheses related to gene function and drug targets, enhancing the translational potential of their findings. Moreover, they offer insights into disease mechanisms, contributing to the development of novel therapeutic strategies.
What sets our LRP2BP Gene Knockout Cell Lines apart is their high specificity, reliability, and the ease of integration into existing research workflows. Unlike traditional cell lines that may exhibit variable expression levels or require extensive modifications, our knockout lines provide a uniform genetic background, thereby enabling reproducible experimental results.
The value of LRP2BP Gene Knockout Cell Lines cannot be overstated, as they empower researchers and clinicians with the tools needed to explore complex biological processes and advance the understanding of diseases. Backed by extensive expertise in genetic engineering and a commitment to innovation, our company is dedicated to providing high-quality biological products that support cutting-edge research and clinical applications, ensuring researchers have access to the best tools for their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.